Published on
Exhibit 21.1
Subsidiaries of bioAffinity Technologies, Inc.
1. OncoSelect Therapeutics, LLC (a Delaware limited liability company)
Form: DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy